NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Telo Genomics Corp (V: TELO)

 
TELO Technical Analysis
5
As on 21st Nov 2025 TELO STOCK Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.08 & Strong Sell for SHORT-TERM with Stoploss of 0.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TELOSTOCK Price

Open 0.06 Change Price %
High 0.06 1 Day -0.01 -16.67
Low 0.04 1 Week 0.00 0.00
Close 0.05 1 Month -0.03 -37.50
Volume 1123547 1 Year -0.07 -58.33
52 Week High 0.16 | 52 Week Low 0.05
 
V Canada Most Active Stocks
SML 1421.34 5.74%
NU 12.03 16.12%
GXU 0.04 0.00%
SMN 0.12 -7.69%
GSVR 0.44 10.00%
PNG 6.00 11.32%
SNS 0.40 -2.44%
ABI 0.08 0.00%
WCU 0.01 0.00%
SPA 0.16 14.29%
 
V Canada Top Gainers Stocks
LEXI 32.91 329000.00%
KUB 7.50 37400.00%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
PRE 1.55 7650.00%
PRE 1.55 7650.00%
HELX 32.31 4096.10%
 
V Canada Top Losers Stocks
GOP-H 0.00 -100.00%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
TZR 0.05 -75.00%
SGMA 4.18 -63.65%
SGMA 4.18 -63.65%
ATI 0.03 -62.50%
ATI 0.03 -62.50%
 
 
TELO
Daily Charts
TELO
Intraday Charts
Whats New @
Bazaartrend
TELO
Free Analysis
 
TELO Important Levels Intraday
RESISTANCE0.09
RESISTANCE0.08
RESISTANCE0.07
RESISTANCE0.06
SUPPORT0.04
SUPPORT0.03
SUPPORT0.02
SUPPORT0.01
 
TELO Forecast November 2025
4th UP Forecast0.17
3rd UP Forecast0.13
2nd UP Forecast0.11
1st UP Forecast0.08
1st DOWN Forecast0.02
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.03
4th DOWN Forecast-0.07
 
TELO Weekly Forecast
4th UP Forecast0.11
3rd UP Forecast0.09
2nd UP Forecast0.08
1st UP Forecast0.07
1st DOWN Forecast0.03
2nd DOWN Forecast0.02
3rd DOWN Forecast0.01
4th DOWN Forecast-0.01
 
TELO Forecast2025
4th UP Forecast0.28
3rd UP Forecast0.21
2nd UP Forecast0.16
1st UP Forecast0.12
1st DOWN Forecast-0.02
2nd DOWN Forecast-0.06
3rd DOWN Forecast-0.11
4th DOWN Forecast-0.18
 
 
TELO Other Details
Segment EQ
Market Capital 25982806.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
TELO Address
TELO
 
TELO Latest News
 
Your Comments and Response on Telo Genomics Corp
 
TELO Business Profile
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada. Address: MaRS Centre, Toronto, ON, Canada, M5G 1L7
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service